Logo-jhp
J Herbmed Pharmacol. 2021;10(4): 443-458.
doi: 10.34172/jhp.2021.52
  Abstract View: 266
  PDF Download: 139

Original Article

Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies

Rehab Fikry Taher 1* ORCID logo, Ahmed A. Al-Karmalawy 2 ORCID logo, Ahmed I. Abd El Maksoud 3 ORCID logo, Hany Khalil 4 ORCID logo, Amr Hassan 5 ORCID logo, Ezzel-Din A. El-Khrisy 1 ORCID logo, Walaa El-Kashak 1 ORCID logo

1 Chemistry of Natural Compounds Department, National Research Centre, 12622 Giza, Egypt
2 Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt
3 Industrial Biotechnology Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt
4 Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt
5 Bioinformatic Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt

Abstract

Introduction: Hymenosporum flavum (Hook.) F. Muell. is the sole species within the genus Hymenosporum is known for its antimicrobial activity. The current study aims to examine the prospective activity of H. flavum as a safe supporter of sorafenib (as a reference standard) against hepatocellular carcinoma (HCC). Methods: Isolation and identification of compounds were made by chromatographic and spectroscopic methods. A fingerprint for the plant extract was done using HPLC-MS/MS spectrometric analysis. The total plant extract was examined in vitro for HCC activity. The isolated flavonoids were examined for their cytotoxic activities using molecular docking studies against both RAF-1 and ERK-2, and the promising compounds were further examined in vitro using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Results: Two new flavonols were isolated from the leaf extract of H. flavum (Hook.) F. Muell., quercetin-3-O-(glucopyranosyl 1→2 ribopyranoside) (1) and kaempferol-3-O-(glucopyranosyl 1→2 ribopyranoside) (2), accompanying other six known flavonoids (3-8), and identified via spectroscopic analysis. Moreover, HPLC- PDA/MS/MS spectrometric analysis revealed the presence of seventy phenolic metabolites. The cytotoxic activity of the plant extract confirmed its potential action on HepG2 cells indicated by the production level of lactate dehydrogenase (LDH) upon treatment compared with the normal cells. The isolated flavonoids were examined for their cytotoxic activity using molecular docking studies against both RAF-1 and ERK-2 as proposed mechanisms of their anticancer activities. Furthermore, compounds 1 and 3, which showed the best in silico results, were further examined in vitro using qRT-PCR. They exhibited promising inhibitory activities against both RAF-1 and ERK-2 gene expression. Moreover, they showed promising cytotoxic activities indicated by the MTT assay. Also, both of them improved the efficiency of sorafenib in targeting both RAF-1 and ERK-2 pathways suggesting synergistic combinations. Conclusion: Our findings showed the potential cytotoxic activity of H. flavum extract on HepG2 cells. Some isolated compounds (1 & 3) exhibited promising inhibitory activities against both RAF-1 and ERK-2 gene expression giving a lead future study for these compounds to be used in pharmaceutical preparations either alone or in combination with sorafenib.
Keywords: Flavonoids, Molecular docking, Raf-1, Erk-2, HPLC/MS/MS, Sorafenib

Implication for health policy/practice/research/medical education:

Compounds isolated from the leaf extract of Hymenosporum flavum showed promising inhibitory activities against both RAF-1 and ERK-2 gene expression. They also showed promising cytotoxic activities indicated by the MTT assay. Thus, the plant phytoconstituents could give a lead structure for drug development strategies against cancer.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 266

Your browser does not support the canvas element.


PDF Download: 139

Your browser does not support the canvas element.

Submitted: 15 May 2021
Revision: 22 Jul 2021
Accepted: 23 Jul 2021
ePublished: 29 Sep 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)